Unveiling the Hidden Lethality Factors in family violence
Cracking Addiction21 Juni 2023

Unveiling the Hidden Lethality Factors in family violence

In this thought-provoking episode of Cracking Addiction, Dr Ferghal Armstrong and Steve Herd delve into the grim reality of family violence, focusing on the evidence-based risk factors for lethality. With a serious tone, they shed light on the Common Risk Assessment Framework, which highlights factors that significantly contribute to the risk of lethality in domestic abuse cases.

Drawing attention to the alarming statistics, the hosts reveal the distressing truth that more than one woman per week in Australia falls victim to fatal violence at the hands of a current or former partner. As the discussion unfolds, Ferghal and Steve underscore the importance of understanding high lethality factors in family violence, particularly the patterns of escalating violence. Steve Herd educates the audience about the chilling escalation of violence against women by partners, wherein physical abuse intensifies from a mere slap to a punch, and sometimes to a devastating push.

Ferghal Armstrong emphasises the grave nature of strangulation as the most significant physical risk factor in these cases. Astonishingly, victims of family violence often fail to disclose incidents of strangulation, further complicating the identification and prevention of lethal outcomes. The hosts shine a light on the often-overlooked risk factor of choking, revealing how victims may not openly admit to experiencing strangulation. Dr Ferghal explains that strangulation poses a risk not only to lethality but also to significant morbidity.

Shockingly, just 15 seconds of strangulation with a firm handshake grip strength is enough to cause urinary incontinence, while a mere 30 seconds can result in fecal incontinence. The episode explores the aftermath of family violence, emphasising that women who have experienced such abuse may downplay their ordeal but later recall waking up to find themselves wet or soiled. Furthermore, Ferghal Armstrong and Steve Herd shed light on the extensive damage strangulation can inflict, including harm to brain arteries, the thyroid gland, cartilage, and the voice box. This comprehensive discussion reveals the range of associated morbidities and illnesses, underscoring the urgent need to recognise and address strangulation as a high-risk factor that is often downplayed or misunderstood.

As the episode concludes, Ferghal Armstrong and Steve Herd leave the audience with a heightened awareness of the hidden dangers within family violence, urging society to take a stand against this pervasive issue and prioritise the safety and well-being of those affected. Note: The content described in the episode summary is of a serious nature, focusing on the severity and impact of family violence. The tone of the description reflects this seriousness and aims to raise awareness about the subject matter.

Avsnitt(218)

LAIB - Sublocade

LAIB - Sublocade

Cracking Addiction discusses Sublocade one of the LAIB preparations available and how to commence, maintain and manage any dose changes or complications associated with Sublocade.Sublocade is a long acting injectable buprenorphine (LAIB) manufactured by Invidior that uses the “Atrigel” system to provide for a sustained and prolonged delivery of buprenorphine into the systemic circulation after subcutaneous injection.Discussions and comments in our videos are for informational purposes only and should not replace the advice of your medical professional. Please consult with your doctor before making any changes to your medical treatment or lifestyle.Latest Blogshttps://www.meducate.com.au/blogAbout Meducate ®Meducate provides online education for doctors, clinicians, health professionals and the public.See the website to browse the many different talks and courses available https://www.meducate.com.au

9 Feb 202215min

LAIB - Buvidal

LAIB - Buvidal

Cracking Addiction discusses Buvidal one of the LAIB preparations available and how to commence, maintain and manage any dose changes or complications associated with Buvidal.Buvidal is a long acting injectable buprenorphine (LAIB) preparation manufactured by Camurus and uses “FluidCrystal” technology to provide for a sustained and prolonged delivery of buprenorphine into the systemic circulation after subcutaneous injection.

3 Feb 202217min

LAIB Special Circumstances

LAIB Special Circumstances

Cracking Addiction discusses some of the special or difficult circumstances of prescribing LAIBs including intoxicated patients, pregnant patients, patients with chronic disease, patients with acute pain and our management strategies in these situations.

26 Jan 202219min

LAIB first dose considerations

LAIB first dose considerations

Episode 23 of Cracking Addiction explores commencement of patients on LAIB, side effects and risks of LAIB, discussion about precipitated withdrawal and when and how to review patients

20 Jan 202220min

Long Acting Injectable Buprenorphine (LAIB) - Introduction

Long Acting Injectable Buprenorphine (LAIB) - Introduction

An Introduction to Long Acting Injectable Buprenorphine (LAIB)Long acting injectable buprenorphine (LAIB) are long acting buprenorphine depot preparations that are injected subcutaneously and provide patients with a sustained release of buprenorphine for the duration of the depot preparation. Currently, two LAIB products are available for the Australian market. They differ in their formulations, administration and pharmacology.See blog for further informationhttps://www.meducate.com.au/blogAbout Meducate ®Meducate provides online education for doctors, clinicians, health professionals and the public.See the website to browse the many different talks and courses availablehttps://www.meducate.com.au

12 Jan 202218min

Methadone pharmacokinetics and interactions

Methadone pharmacokinetics and interactions

Episode 21 of Cracking Addiction explores methadone pharmacokinetics, breakdown and interactions within the body and interactions with other drugs.Methadone is a drug with a wide variability in its absorption with oral bio-availability ranges from 35% to 100%. This is a significant amount of variability and explains why the same dose of Methadone can impact different patients differently. Methadone is metabolised within the liver by the cytochrome P450 enzymes but mainly 3A4. There is a 17-fold inter-individual variation of methadone blood concentration for a given dosage and variations in metabolism account for a large part of this variation. Kinetic interactions influenced by the CYP 450 enzyme can affect plasma methadone levels.• Inducers of CYP450 can• Accelerate the metabolism of methadone• lower methadone plasma levels• Precipitate opioid withdrawal • Inhibitors of CYP450 can • Slow the metabolism of methadone• Increase plasma levels• Produce opioid toxicity (sedation, overdose)Methadone is excreted renally with approximately 10% of drug renally eliminated unchanged. Renal excretion of methadone urinary pH dependent with increased Methadone excretion noted at pH less than 6 and decreased Methadone excretion at higher pH levels.About Meducate ®Meducate provides online education for doctors, clinicians, health professionals and the public.See the website to browse the many different talks and courses availablehttps://www.meducate.com.au

22 Dec 202116min

Methadone pharmacology and induction

Methadone pharmacology and induction

Episode 20 of Cracking Addiction explores methadone, its origins, the pharmacology behind methadone and how to commence a patient on Methadone.Methadone is a synthetic long acting mu receptor agonist suitable for the treatment of opioid use disorder. Methadone has a longer plasma half life than morphine (average 22 hours (15-32 hours) vs 2 hours for morphine) which permits once daily supervised dosing.https://www.meducate.com.au/blogAbout Meducate ®Meducate provides online education for doctors, clinicians, health professionals and the public.See the website to browse the many different talks and courses availablehttps://www.meducate.com.au

15 Dec 202122min

Opioid use disorder Post Partum

Opioid use disorder Post Partum

Episode 19 of Cracking Addiction explores the management of opioid use disorder in the post partum period.Post birth the patient's usual oral methadone dose can be continued in the peripartum and post partum period. There is a theoretical concern in the postpartum period of over-sedation as methadone levels may increase as plasma volume and hepatic clearance normalise post the delivery of the child. Latest Blogshttps://www.meducate.com.au/blogAbout Meducate ®Meducate provides online education for doctors, clinicians, health professionals and the public.See the website to browse the many different talks and courses availablehttps://www.meducate.com.au

9 Dec 202111min

Populärt inom Hälsa

rss-bara-en-till-om-missbruk-medberoende-2
somna-med-henrik
alska-oss
inga-beiga-morsor
johannes-hansen-podcast
sexnoveller-deluxe
angestpodden
rss-viktmedicinpodden
sova-med-dan-horning
rss-the-house-podcast-3
rss-sjalsligt-avkladd
giggles-med-wiggles
not-fanny-anymore
rss-the-house-podcast-4
sa-in-i-sjalen
sag-det-bara
brottarbroder
medicinvetarna
rss-sexmorgon
tyngre-radio